TSE:6869Medical Equipment
What Sysmex (TSE:6869)'s Nu.Q NETs Collaboration With VolitionRx Means For Shareholders
In June 2026, VolitionRx Limited announced it had entered into a collaboration with Sysmex Corporation to optimize VolitionRx’s Nu.Q NETs H3.1 assay on Sysmex’s platform, following successful transfer of the assay and with a focus on diseases linked to NETosis.
The agreement opens access to a very large US$3.80 billion total addressable market for the Nu.Q NETs assay, which could broaden Sysmex’s role in specialized diagnostics.
Next, we examine how integrating the Nu.Q NETs assay into...